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Abstract
Mounting evidence links prenatal exposure to maternal tobacco smoking with disruption of
DNA methylation (DNAm) profile in the blood of infants. However, data on the postnatal sta-
bility of such DNAm signatures in childhood, as assessed by EpigenomeWide Association
Studies (EWAS), are scarce. Objectives of this study were to investigate DNAm signatures
associated with in utero tobacco smoke exposure beyond the 12th week of gestation in
whole blood of children at age 5.5 years, to replicate previous findings in young European
and American children and to assess their biological role by exploring databases and
enrichment analysis. DNA methylation was measured in blood of 366 children of the multi-
centre European Childhood Obesity Project Study using the Illumina Infinium HM450
Beadchip (HM450K). An EWAS was conducted using linear regression of methylation val-
ues at each CpG site against in utero smoke exposure, adjusted for study characteristics,
biological and technical effects. Methylation levels at five HM450K probes inMYO1G
(cg12803068, cg22132788, cg19089201), CNTNAP2 (cg25949550), and FRMD4A
(cg11813497) showed differential methylation that reached epigenome-wide significance
according to the false-discovery-rate (FDR) criteria (q-value<0.05). Whereas cg25949550
showed decreased methylation (-2% DNAm ß-value), increased methylation was observed
for the other probes (9%: cg12803068; 5%: cg22132788; 4%: cg19089201 and 4%:
cg11813497) in exposed relative to non-exposed subjects. This study thus replicates previ-
ous findings in children ages 3 to 5, 7 and 17 and confirms the postnatal stability ofMYO1G,
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CNTNAP2 and FRMD4A differential methylation. The role of this differential methylation in
mediating childhood phenotypes, previously associated with maternal smoking, requires
further investigation.
Introduction
There is growing evidence from both candidate gene [1] and Epigenome Wide Association
Studies (EWAS) that prenatal exposure to maternal tobacco smoking substantially alters DNA
methylation (DNAm) in newborn blood [2–6]. Evidence also exists for dosage, tissue-specific
and timing of exposure effects. Importantly, several of these studies have reported similar find-
ings, with changes in methylation consistently observed at AHHR, CNTNAP2, CYP1A1, GFI1
andMYO1G at birth.
Recently, the postnatal stability of maternal smoking-associated differential methylation has
been investigated. An EWAS using the Illumina Infinium HumanMethylation450 BeadChip
(HM450K), conducted in 12- to 18-year old offspring of mothers who smoked during preg-
nancy [6] found persistence of differentially methylated regions (DMRs) inMYO1G and
CNTNAP2. A similar study using longitudinal blood samples collected at birth, at age 7 and
age 17 years [7], demonstrated that some smoking-associated DMRs are time-stable postna-
tally (AHRR,MYO1G, CYP1A1, CNTNAP2), whereas others are not (ATP9A, GFI1, KLF13).
Importantly, both the duration and intensity (cigarettes/day) appear important in the observed
effect. Despite these findings, no equivalent EWAS has yet been carried out in blood of children
younger than 7, except a very recent study in 3–5 year old US children [8] using EWAS data to
replicate 26 differently methylated CpG sites previously reported in newborns [2].
In order to further explore the postnatal stability of maternal smoking induced epigenetic
change in early childhood, we carried out an EWAS in 366 children at 5.5 years of age as part
of the multicentre study of the European Childhood Obesity Project Study (CHOP) [9]. In
addition, we explored biological databases and performed enrichment analysis to get some bio-
logical insight into the role of MYO1G, CNTNAP2 and FRMD4A.
Results
Overall 5 CpG sites in genesMYO1G (three sites), CNTNAP2 and FRMD4A showed epigen-
ome-wide significance according to the FDR criteria (Table 1).
EWAS significance and effect size of 431 313 analysed CpG sites are illustrated also by vol-
cano plot and QQ-plot (Fig 1).
The location of differentially methylated CpG sites inMYO1G, CNTNAP2 and FRMD4A is
depicted in Fig 2.
The three significant differentially methylated CpG sites inMYO1G were situated at the 3’
gene region, in a CpG island (cg22132788, cg19089201) and the 2kb region downstream of this
CpG island, i.e. in an S shore (cg12803068) (Fig 2A). The significantly methylated CpG in
CNTNAP2 gene was situated in S shore (cg25949550), close to the transcription start site (TSS)
(Fig 2B). One significantly methylated CpG site in FRMD4A (cg11813497) was located down-
stream of the TSS (Fig 2C). Amongst the top 25 differentially methylated CpG sites in association
with maternal smoking were other previously reported CpGs inMYO1G (cg04180046) and
FRMD4A (cg15507334) genes (Table 1), but these did not survive correction for multiple testing.
CpGs showing significant differential methylation in association with maternal smoking
after week 12 of gestation generally showed positive associations;MYO1G, +9% at cg12803068,
+5% at cg22132788 and +4% at cg19089201; FRMD4A, +4% at cg11813497. In addition,
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cg04180046 at the 3’region ofMYO1G showed a +5% difference and cg15507334 at the 5’
region of FRMD4A a +4% difference in mean CpG methylation between exposed and unex-
posed children but both did not reach FDR significance.
In contrast, cg25949550 in the S shore of CNTNAP2 gene showed a difference of minus 2%
in mean DNAmethylation between exposed and unexposed children (Table 1).
Direction and effect sizes of differential methylations inMYO1G and CNTNAP2 genes
found in the CHOP cohort (5.5 years) were quite similar with those from other EWAS based
on Illumina 450K arrays from SEED (5 years), ALSPAC (7.5 and 17.7 years) and SYS (15.6
years) cohorts (S1 Table) [6–8].
Table 1. Top 25 EWAS associations of differentially methylated CpG sites in children at age 5.5 years exposed to maternal smoking beyond week
12 of gestation.
CpG ID CHR Gene Position (bp) DNAm ß-value difference (SE) P-value FDR
cg12803068 7 MYO1G 45002919 0.09 (0.02) 7.15E-10 3.09E-04
cg25949550 7 CNTNAP2 145814306 -0.02 (0.00) 1.57E-09 3.38E-04
cg22132788 7 MYO1G 45002486 0.05 (0.01) 1.73E-08 2.49E-03
cg11813497 10 FRMD4A 14372879 0.04 (0.01) 2.17E-07 2.34E-02
cg19089201 7 MYO1G 45002287 0.04 (0.01) 5.69E-07 4.91E-02
cg27181554 16 SEPX1 1992734 -0.02 (0.00) 1.49E-06 9.35E-02
cg21376136 2 CACNB4 152830572 0.05 (0.01) 1.52E-06 9.35E-02
cg23222488 5 176755393 0.05 (0.01) 9.02E-06 4.77E-01
cg03480605 7 NUB1 151038446 0.04 (0.01) 9.95E-06 4.77E-01
cg17745339 5 176755199 0.05 (0.01) 1.21E-05 5.20E-01
cg00173010 7 DAGLB 6487342 0.00 (0.00) 1.81E-05 7.11E-01
cg10427827 12 132929654 0.01 (0.00) 2.54E-05 8.68E-01
cg25959131 3 DOCK3 50855436 0.04 (0.01) 2.95E-05 8.68E-01
cg15507334 10 FRMD4A 14372913 0.04 (0.01) 3.07E-05 8.68E-01
cg11025974 2 CACNB4 152830521 0.03 (0.01) 3.17E-05 8.68E-01
cg26624744 5 CYFIP2 156692507 -0.02 (0.01) 3.34E-05 8.68E-01
cg03287111 2 GLI2 121625634 0.04 (0.01) 3.59E-05 8.68E-01
cg15775217 12 TXNRD1 104676774 0.18 (0.04) 3.74E-05 8.68E-01
cg04180046 7 MYO1G 45002736 0.05 (0.01) 3.82E-05 8.68E-01
cg25292698 18 MYL12A 3247809 -0.01 (0.00) 4.48E-05 9.66E-01
cg14362178 2 79007750 -0.07 (0.02) 4.90E-05 1.00E+00
cg05655457 11 OR5B17 58127944 -0.04 (0.01) 5.33E-05 1.00E+00
cg08237309 16 PKD1 2146423 0.00 (0.00) 5.53E-05 1.00E+00
cg21428148 18 NDUFV2 9102454 0.00 (0.00) 5.81E-05 1.00E+00
cg18882449 10 NT5C2 104885122 0.05 (0.01) 6.17E-05 1.00E+00
Table is based on regression analysis of 431313 CpGs in 366 children. CpG ID: CpG site identiﬁcation number and CHR: chromosome according to
annotation. Gene: CpG related gene name according to annotation; Position (bp): Chromosome position is based on NCBI Human Reference Genome
Assembly Build 37. DNAm ß-value difference is the adjusted mean difference in differentially methylated ß-values among in utero tobacco exposed vs. not
exposed children for those 25 CpG sites identiﬁed by the M-value based EWAS regression models described below; e.g. 0.09 means that the difference in
the proportion of DNA methylation between exposed and unexposed children is 09. P-value: uncorrected p-value obtained by standard linear regression
of M-values of DNA methylation at respective CpG site (outcome) on indicator coded in utero tobacco exposure by maternal smoking during pregnancy
(main predictor) adjusted for sex, age at blood draw, indicator coded country of study centre, maternal education, exposure to parental smoking at age 4
years, the estimated proportions of six major white blood cell (WBC) types, CD4+ T cells, CD8+ T cells, B cells, NK cells, monocytes and granulocytes,
and the 30 principal components (PC) derived from control probes (see methods section). FDR: p-value corrected for multiple testing according to
Benjamin-Hochberg (false discovery rate).
doi:10.1371/journal.pone.0155554.t001
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Functional Network and Enrichment Analysis
The PANTHER Classification System (http://pantherdb.org/index.jsp) [10] showed in the pre-
dicted network of 100 proteins associated with MYO1G, CNTNAP2 and FRMD4A (S2 Table)
created by GeneMANIA ((http://genemania.org/) [11] a more than 5-fold enrichment for the
following pathways: Nicotine pharmacodynamics pathway (P06587), Dopamine receptor
mediated signalling pathway (P05912), Axon-guidance mediated by semaphorins (P00007)
and Ras pathway (P04393) (S3 Table).
Some of the strongest overrepresented GO terms were protein localization to juxtaparanode
region of axon (GO:0071205), neuron recognition (GO:0008038), axonogenesis (GO:0050770),
cell-substrate adhesion (GO:0031589), neuron projection guidance (GO:0097485) and
included other biological processes linked to cytoskeleton organization, cell migration and
motility (S4 Table). For a complete list of significant GO terms linked to molecular function
and cellular localisation see S5 and S6 Tables.
PANTHER protein classes in this network were>5-fold enriched (Bonferroni-adjusted
P-value<0.05) for actin binding motor proteins (PC00040), cell junction proteins (PC00070),
actin family cytoskeletal proteins (PC00041) and G-protein modulators (PC00022) see
S7 Table.
Discussion
This study aimed to identify associations between in utero exposure to maternal smoking and
DNAmethylation levels in blood of 366 European children of age 5.5 years. Overall five CpG
sites in gene regionsMYO1G (cg12803068, cg22132788, cg19089201), CNTNAP2
(cg25949550) and FRMD4A (cg11813497) showed epigenome-wide significance. Interestingly,
the CpG sites we identified in the CNTNAP2 andMYO1G genes were the same as those previ-
ously reported in newborns [2], 3–5 year old children [8], for adolescents at age 12–16 years
[6] and longitudinally in newborns, 7 year old children and 17 year old adolescents [7].
Fig 1. Volcano plot (A) and QQ-plot (B) of 433 313 differentially methylated CpG sites for 366 children at age 5.5 exposed vs.
not-exposed to maternal smoking beyond week 12 of gestation. Figures are based on linear regression of M-values on exposure
variable and adjustment factors.
doi:10.1371/journal.pone.0155554.g001
Smoke Exposure in Pregnancy and DNA-Methylation
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Fig 2. Regional association of CpGmethylation atMYO1G (A),CNTNAP2 (B) and FRMD4A (C) loci
with prenatal smoking status. The direction of differential methylation is marked with arrows (" increase or
Smoke Exposure in Pregnancy and DNA-Methylation
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Moreover, the effect size and direction of effect were more or less equivalent across these stud-
ies, highlighting the reproducibility of findings and postnatal stability of in utero smoking
exposure–associated DNA methylation disruption in these genes.
The differentially methylated CpG site cg11813497 in the promoter region of FRMD4A in
our study has previously been reported in a single EWAS in blood of newborns with the largest
proportion of smoking mothers yet examined [3]. However, whereas that study identified 3
other FRMD4A related CpG sites (cg2034448, cg25464840, cg15507334) these were not signifi-
cantly differentially methylated in our dataset [3]. One of these sites (cg25464840) was also
reported in an EWAS of 5–12 year old children [12]. As only one of these previous reported
CpG sites in FRMD4A (cg15507334) was among the top 25 ranked p-values in our study, it is
interesting to speculate that whereas differential methylation at CpG site cg11813497 may
show throughout childhood, this may not be the case for the other 2 CpG sites in this gene.
However, equally likely is that the reduced power of our study, relative to previous studies [3]
played a role in our findings.
Several other differently methylated regions (DMR) in children or adolescents associated
with maternal smoking during pregnancy in previous EWAS, e.g. CpGs related to AHRR or
CYP1A1 in the study [6,7] did not show significance in our EWAS analyses.
Biological meaning of CpG sites sensitive to maternal smoking during
pregnancy
Prenatal tobacco smoke exposure is associated with a wide range of adverse health outcomes in
offspring. Children of smoking mothers have an increased risk of speech-processing and atten-
tion control deficits [13,14], autism [15], allergy [16], asthma [17], overweight and obesity [18]
and nicotine dependency [19]. Interestingly, MYO1G, CNTNAP2 and FRMD4A gene prod-
ucts have been previously been associated with many of these outcomes and differential DNA
methylation across their gene loci has been consistently replicated in the blood of newborns or
youth exposed to in utero tobacco smoke. However, the functional relevance of these DMRs at
CNTNAP2,MYO1G and FRMD4 is limited. Therefore, we investigated publicly available epi-
genome and transcriptome databases and performed functional network and enrichment anal-
ysis to gain insights into the potential functional relevance of the observed differential
methylation in these genes.
MYO1G. Smoking-associated increased methylation atMYO1G (cg19089201,
cg22132788, cg04180046, and cg12803068) is located in a CpG island and S shore in the 3’
gene region (S1 Fig). It has been detected both in offspring exposed to prenatal smoking [2,5–
8] and in adult smokers [20–24].
Increased methylation in this gene region might correlate with increasedMYO1G transcrip-
tion according to three lines of evidence. First, the DNAmethylation and gene expression data-
base MethHC [25] shows that in urogenital cancer the methylation at 3’ gene region of
MYO1G positively correlates with transcription, contrary to the promoter/5’UTR region meth-
ylation (S2 Fig). Second, The Encyclopedia of DNA Elements (ENCODE) [26] evidence of
DNAmethylation in three blood and endothelial cell lines (GM12878, K562 and HUVEC) by
Illumina 450K shows that high methylation (>60%) in the 3’MYO1G region and low methyla-
tion (<20%) in the 5’ gene region correlate with highMYO1G transcription in GM12878 (S1
# decrease). Regional association plots are shown using the gene map (UCSC genome browser, hg19) with
a graph of–log10 p-values on the y-axis, the nucleotide position on the x-axis, and the position of selected
Illumina Infinium HumanMethylation 450 BeadChip probes. Abbreviations: CGI: CpG island; TSS:
transcription start site; FDR: false discovery rate p-value.
doi:10.1371/journal.pone.0155554.g002
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Fig) [27]. On the contrary, in K562 and HUVEC cell lines whereMYO1G transcription is
absent [28], methylation at the 3’ gene region is low (<20% in HUVEC) while the 5’ gene
region methylation is high (>60% in K562 and HUVEC) (S1 Fig). Third, methylation in the 3’
MYO1G gene body (cg04180046) was recently reported to positively correlate withMYO1G
transcription in leukocytes of 144 healthy Chinese adults in an EWAS of smoking [24]. Thus,
these data support the observation that, unlike promoter methylation, gene body methylation
inMYO1Gmight correlate with its active transcription [29].
The 3’MYO1G gene region might have a regulatory role since it overlaps with monomethy-
lated and trimethylated lysine 4 on histone H3 (H3K4) and binding sites for Myc, Max, YY and
USF transcriptional factors (S3 Fig). It also binds transcriptional repressors such as EZH2, a
histone-lysine N-methyltransferase involved in regulation of histone and DNA methylation
[30] and CTCF, an insulator protein that affects mRNA splicing, promoter-enhancer looping
and whose binding affinity is modulated by DNAmethylation [31].
Exposure to nicotine may change leukocyte numbers and increase leukocyte-endothelial
adhesion [32]. This goes in line with GO terms in our pathway analysis such as cell migration
(GO:0016477), localization of cell (GO:0051674), cell motility (GO:0048870), movement of cell
or subcellular component (GO:0006928) and cell adhesion (GO: 0007155). Moreover, MYO1G
might be implicated in transmission of smoking effects on cardiovascular system [33] since
this type I unconventional myosin is specifically expressed in the plasma membrane of B and T
lymphocytes and mast cells [28,34] and regulates leukocyte adhesion, mobility and phagocyto-
sis [35–37].
Sensory perception of sound (GO: 0007605) was another overrepresented biological term in
our pathway analysis, which might by associated with impaired auditory processing in infants
exposed to prenatal smoking [38]. However, this overrepresentation might be also due to the
presence of other nonconventional myosins such as MYO1B, MYO1C and MYO1E in our
interaction network. Unlike MYO1G, they are also expressed in sensory cells of the inner ear
[39] and their mutations have been associated with hearing loss [40].
Based on current knowledge, it would be of interest to understand the mechanisms that
keep 3’MYO1G gene region differentially methylated even after the withdrawal of tobacco tox-
ins and what role this plays for phenotypes related to child development.
CNTNAP2. Decreased methylation at CNTNAP2 (cg25949550) has been reported both in
offspring exposed to prenatal smoking [2,5–7] and in adults [22,24]. It is located in S shore,
~800 bp downstream of the transcriptional start site, and overlaps with binding sites of several
transcriptional repressors such as SIN3A, CTCF, REST and CTBP2 (S4 Fig). Adult smokers
also show decreased methylation at nearby cg21322436 [22,24] and cg16254309 [41]. These
two CpGs are located in N shores and S shores (0-2kb regions upstream and downstream of
CGI, respectively) in the 5’ gene region (Fig 2B, S4 Fig). In addition, adult smokers also show
increased methylation at cg11207515 and cg1737210 that are located>1 Mb (mega base pairs)
downstream of the CNTNAP2 transcriptional start site (Fig 2B) [22–24]. These DMRs found
in blood of adult smokers have not yet been found in offspring in association with the exposure
to prenatal tobacco smoke.
Given the evidence from Gene Expression Atlas [42] that tobacco down-regulates
CNTNAP2 transcription in cancerous human lung tissue (E-GEOD-13309) and normal
human bronchial epithelial cells (E-GEOD-10718) [43,44], we speculate that CNTNAP2 tran-
scription could also be downregulated in individuals exposed to tobacco smoke. Whether this
could be mediated through methylation decrease in one CpG and increased recruitment of
transcriptional repressors remains to be addressed. This might even be detectable in blood
since CNTNAP2 protein expression has also been found in B lymphocytes and endothelial
cells [45,46].
Smoke Exposure in Pregnancy and DNA-Methylation
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CNTNAP2 is a cell adhesion protein whose decreased expression leads to aberrant neuro-
nal migration and was included in some of our overrepresented GO terms such as ‘protein
localization to juxtaparanode region of axon’ (GO:0071205), ‘neuron recognition’
(GO:0008038) and ‘neuron projection development’ (GO:0031175). Since CNTNAP2 muta-
tions have been linked with impaired language development, autism spectrum disorder and
intellectual disability [47], it is possible that the prenatal smoking-associated methylation in
CNTNAP2 and its persistency until at least adolescence [6,7] might represent an additional
mechanism contributing to impaired neurodevelopment in children exposed to in utero
tobacco smoke.
FRMD4A. Increased methylation in FRMD4A (cg20344448, cg11813497, cg25464840 and
cg15507334) has been associated with prenatal smoking in newborns [3,5] and children [12]
but not observed in adult smokers. These CpGs are situated in the potential promoter/5’UTR
region (Fig 2C), which in neuroblastoma cells binds GATA-2 (S5 Fig), a hematopoietic tran-
scription factor that regulates proliferation of blood cell lineages. Interestingly, binding of
GATA-2 to target genes is prevented by DNAmethylation during lymphoid differentiation
[48]. In vitro experiments suggest that smoking might modulate FRMD4A transcription since
FRMD4A expression in human bronchial cells treated with tobacco smoke condensate was
upregulated (E-GEOD-14383) [49]. However, no relation between DNA methylation and
expression of FRMD4A was found in 526 adults used for replication of EWAS findings related
to prenatal smoking exposure in older children [12].
Prenatal exposure to nicotine exerts strong effects on cytoskeleton reorganization and
increases expression of cytoskeletal proteins [50]. Our functional network analysis was over-
represented for 2 GO terms related to morphogenesis (GO:0009653 and GO:0032989), both of
which included FRMD4A and MYO1G. FRMD4A is a scaffold protein that regulates epithelial
polarization and cell-cell junctions [51] and its upregulation increases intercellular adhesion
[52]. The influence of prenatal nicotine on cytoskeleton organization is further supported by
overrepresented PANTHER Pathways such as Dopamine receptor mediated signalling
(P05912) and Nicotine pharmacodynamics (P06587) pathways. Although they did not include
FRMD4A, the EPB41L1 erythrocyte cytoskeleton protein that shares the FERM-C protein
domain with FRMD4A was found in both of these pathways. Interestingly, EPB41L1 and its
related protein EPB41L3 interact with CNTNAP2 in brain where they may anchor this axonal
transmembrane protein to the actin cytoskeleton [53].
The relevance of promoter DNA methylation on FRMD4A function in development
remains unclear. Since mutations in FRMD4A gene locus associate with nicotine dependence
[54], prenatal smoking-induced DNA methylation of FRMD4A that persists until childhood
might be an additional mechanism contributing to increased nicotine dependency of offspring
exposed to in utero tobacco smoke [19,55].
Strengths and limitations
With the exception of a very recent replication study in 3–5 year old US children [8] our study
is the first comprehensive EWAS with the HM450K BeadChip addressing the effect of contin-
ued in utero tobacco smoke exposure in children of age 5.5 years from four different European
populations (Belgian, German, Italian and Spanish).
This complements previous EWAS that were conducted in British, Norwegian and French-
Canadian populations [6,7,12] at different ages from birth to age 17 years. Although our sam-
ple size is reasonable large (n = 366), as is the exposure group (n = 58), it is likely that it was
somewhat underpowered to detect smaller effects sizes at all genomic loci likely to be sensitive
to methylation disruption in association with maternal smoking in utero. Future meta-analyses
Smoke Exposure in Pregnancy and DNA-Methylation
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across multiple cohorts using the HM450K platform should now be performed to further
define the scope of methylation disruption associated with this exposure in pregnancy.
Conclusions
This EWAS showed effects of continued in utero tobacco smoke exposure beyond 12th week of
gestation on the methylation profile of children at age 5.5 years in Belgian, German, Italian and
Spanish populations. We replicated previous findings confirming the postnatal stability of
methylation disruption atMYO1G and CNTNAP2 genes in association with in utero exposure
to maternal smoking throughout pregnancy and confirmed differential methylation of a CpG
site in FRMD4A that was previously found only in newborns.
The consistent replication of these methylated CpG sites and the exploration of biological
databases combined with enrichment analysis suggests that their biological function and
health-related phenotypes should be further explored.
Material and Methods
Study design and analysed population
The study population used is a subset of 366 children out of 543 children aged 5.5 years from
study centres in Germany, Belgium, Italy and Spain of the European Childhood Obesity Trial
Study (CHOP) registered at clinicaltrials.gov as NCT00338689 and URL: http://clinicaltrials.
gov/ct2/show/NCT00338689?term=NCT00338689&rank=1.
Inclusion criteria were availability of blood buffy coats collected at age 5.5, valid exposure
data on maternal smoking during pregnancy and information on basic characteristics of
mother and offspring (sex, age of blood draw, country of study centre).
Characteristics of the analysed study population are listed in Table 2.
Details on this ongoing prospective nutritional intervention trial with n = 1678 enrolled
healthy infants around birth (n = 550 higher protein formula, n = 540 lower protein formula,
n = 588 breastfed) have been published previously [9,56].
Ethics Statement
The study was conducted according to the principles expressed in the Declaration of Helsinki.
The local ethics committees of each study center approved all study procedures: Belgium
(Comitè d’Ethique de L’Hopital Universitaire des Enfants Reine Fabiola; no. CEH 14/02), Ger-
many (Bayerische Landesärztekammer Ethik-Kommission; no. 02070), Italy (Azienda Ospeda-
liera San Paolo Comitato Etico; no. 14/2002), Poland (Instytut Pomnik–Centrum Zdrowia
Dziecka Komitet Etyczny; no 243/KE/2001), and Spain (Comité ético de investigación clinica
del Hospital Universitario de Tarragona Joan XXIII). Written informed parental consent was
obtained for each infant.
Assessment of child’s smoking exposure during pregnancy
In utero tobacco exposure was derived from maternal questionnaires administered during the
first 8 weeks after delivery:
“Did the child's mother smoke during early pregnancy (up to the 12th week of gestation)?”
“Did the child's mother smoke in the further course of pregnancy (beyond the 12th week of
gestation)?”
Only 18 of 76 mothers who reported smoking in pregnancy ceased after the 12th week of
gestation. Given previous findings demonstrating the necessity for prolonged exposure [8,57],
results are reported only for mothers who smoked throughout pregnancy. The analysed
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exposure variable was coded 1, if the child was exposed to maternal smoking beyond the 12th
gestational week and 0 if not exposed beyond this point. Exposure was set to missing if a child
was exposed only up to 12th week of gestation.
Measurement of epigenome-wide DNAmethylation
During child’s physical examination at age 5.5 years blood was drawn to collect peripheral
blood cells from buffy coats. Genomic DNA was extracted from buffy coats using a standard
precipitation procedure. Bisulfite conversion of 800 ng genomic DNA was conducted with the
EZ-96 DNAMethylation Kit (Zymo Research, Irvine, Ca; USA) and converted DNA samples
were hybridised on the Infinium HumanMethylation450 BeadChip (HM450K) according to
the manufactures instructions (Illumina Inc., San Diego, USA). DNA extraction, bisulfite con-
version and methylation analysis were performed at the Genome Analysis Center of Helmholtz
Zentrum Muenchen, Munich, Germany.
DNA samples were randomly assigned to each of the 33 HM450K slides each containing 12
arrays and processed in one batch by the same laboratory staff to reduce potential batch effects.
The HM450K platform measures methylation at 485577 CpG sites located throughout the
genome [58]. It covers 21231 (99%) genes of the UCSC RefGenes and has a coverage of 96% of
the CpG islands (CGI), 92% of the CGI shores (0–2 kb from CGI), 86% of the CGI shelves (2–4
kb from CGI) and interrogates 16232 differentially methylated regions (DMR).
DNA methylation (DNAm) status at each HM450K probe was determined as methylation
ß-value derived from the intensity ratio of the methylated allele (M) to the sum of intensities of
Table 2. Characteristics of the analysed population.
Characteristic not exposed exposed exposed vs. not Total
(n = 308) (n = 58) p-value (n = 366)
Girls (n (%)) 163 (52.9) 25 (43.1) 0.172 188 (51.4)
Child's age at blood draw (months) 66.4 ± 0.8 66.6 ± 0.8 0.177 66.4 ± 0.8
Girls birthweight (kg) 3.3 ± 0.3 3.0 ± 0.3 < .0001 3.2 ± 0.3
Boys birthweight (kg) 3.3 ± 0.3 3.2 ± 0.4 0.030 3.3 ± 0.3
Child formula vs. breastfed (%) 190 (61.7) 52 (89.7) < .0002 242 (66.1)
Length of gestation (week) 39.8 ± 1.2 39.8 ± 1.4 0.920 39.8 ± 1.2
Maternal age at delivery (years) 31.9 ± 4.2 32.6 ± 4.2 0.276 32 ± 4.2
Maternal education
Low (n (%)) 38 (12.4) 24 (41.4) < .0001 62 (17)
Middle (n (%)) 163 (53.3) 27 (46.6) 0.349 190 (52.2)
High (n (%)) 105 (34.3) 7 (12.1) 0.002 112 (30.8)
Country of study centre
Germany (n (%)) 29 (9.4) 2 (3.4) 0.152 31 (8.5)
Belgium (n (%)) 58 (18.8) 10 (17.2) 0.775 68 (18.6)
Italy (n (%)) 122 (39.6) 14 (24.1) 0.028 136 (37.2)
Spain (n (%)) 99 (32.1) 32 (55.2) 0.001 131 (35.8)
Smoke exposure at age 4 years
by child's mother (n (%)) 31 (10.1) 40 (69.0) < .0001 71 (19.4)
by child's father (n (%)) 75 (24.4) 27 (46.6) 0.001 102 (27.9)
Exposed: Child exposed to any in utero tobacco smoking by maternal smoking during pregnancy beyond 12th week of gestation; Not Exposed: no
exposure to in utero tobacco smoking at any time during pregnancy. P-value: test of percent or mean difference in study population characteristic among
exposed vs. not exposed group either by chi-square test or t-test.
doi:10.1371/journal.pone.0155554.t002
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the unmethylated allele (U) and the methylated allele (M) plus an offset of 100 [58]. As individ-
ual blood samples contain many genomic copies of each CpG site, the calculated ß-value can
be interpreted as the percentage of methylation at that interrogated CpG site for that specific
sample with a range from 0 (= completely unmethylated) to 1 (= completely methylated).
Methylation ß-values were converted to M-values for statistical analyses by taking the base 2
logarithm of the ratio of the raw methylation ß-value and 1 minus the ß-value [59].
Quality control and normalisation of methylation data
Data pre-processing and normalisation were performed mainly according to the approach of
Touleimat and Tost [60] with some adaptions e.g. the beta-mixture quantile normalization
(BMIQ) step of the ß-values [61] as recommend by a recent review of pre-processing and nor-
malisation procedures [62].
Data were only retained for probes that had signals from at least 3 functional beads on the
array and had detection p-values p0.01. Moreover, only samples with at least 80% significant
probe methylation signals per sample were retained. Colour bias correction using smooth
quantile normalisation, and background adjustment based on negative control probes were
conducted separately for the two colour channels with R-package lumi. Lumi was also used for
signal background correction by subtraction of the negative control probe signal. Several fea-
tures of the process of pre-processing used in this study were described previously in more
detail [63]. In contrast to previous approaches [60], no probe filtering according to proximity
of CpG site with SNPs of minor allele frequency5% within 50bp was conducted. In addition,
probes on the X and Y chromosomes were not excluded. However, after BMIQ-normalisation
and removal of duplicates, identified cross-binding probes were excluded as previously
described [64] leaving a final data set of 431313 CpGmethylation values in each of 366 children
for EWAS analysis.
Batch effects and other technical noise was assessed by principal components analysis
(PCA) of control-probes and accounted for by adjustment for principal components (PC) in
the EWAS analysis [65]. Heterogeneity of cell mixture distribution in the samples were
assessed and accounted for by Houseman’s method [66]. In detail, we used the validation data
set consisting of purified cell samples as described in [66] (CD4+ T cells, CD8+ T cells, B cells,
NK cells, monocytes and granulocytes) as a reference to estimate the relationship between cell
types and methylation. After data pre-processing, we extracted ß-values of the 475 methylation
sites available in our study that were overlapping with the 500 methylation sites showing the
strongest relation with cell types in [66]. These data were used to estimate proportions of the
six above-mentioned cell types in samples of the CHOP study using the R function pro-
jectWBC() provided by Andres Houseman, restricting the WBC estimates to positive numbers
(option nonnegative = TRUE). The estimated WBC proportions were included as covariates in
the regression models (see below).
Statistical Analysis (EWAS)
Potential associations between methylation M-values at each CpG site and prenatal exposure
to tobacco smoke beyond the 12th week of gestation were determined by standard linear regres-
sion models with adjustment for sex, age at blood draw (months), study centre (Germany
(DE), Italy (IT), Spain(ES), reference Belgium (BE)), maternal education (high = 12+ yrs. vs.
low = basic schooling and middle (10 -<12 yrs. vs. low), postnatal smoking exposure at age 4
years (by mother (yes/no), by father(yes/no)), the estimated proportions of six major white
blood cell types, CD4+ T cells, CD8+ T cells, B cells, NK cells, monocytes and granulocytes and
the top 30 principal components (PC) derived from control probes on the HM450K platform.
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The latter were included to account for biological and technical noise and batch effects [65,66].
The former adjustment factors were selected based on previous studies [6–8] and to account
for the study design of the CHOP study (multi-centre study with populations from 4 European
countries) [9]. Model adjustment for child’s sex, age at blood draw, study centre, maternal edu-
cation and postnatal smoke exposure was also conducted because lambda (λ) [67] was substan-
tially improved from a model adjusted for cell mixture only (λ = 1.26), over a model adjusted
for cell-mixture and 30 PC (λ = 0.98) to the final fully adjusted model (λ = 0.91).
An association of a differently methylated CpG site (M-values) with exposure was consid-
ered significant at the epigenome-wide level, if the false discovery rate (FDR) was below 0.05
[68]. EWAS-wide significance was also evaluated and illustrated by QQ-plots produced with
module gcontrol2 of R-package gap. Volcano plots of the M-value based regression coefficients
of the exposure variable were used to simultaneously illustrate effect size and EWAS
significance.
Functional characterization of methylated CpGs
Differentially methylated sites were annotated according to Illumina (www.illumina.com,
HumanMethylation450_15017482_v1.csv) and viewed in the UCSC genome browser,
GRCh37/h19 assembly [69]. The location of overlapping transcription factor binding sites,
transcripts and chromatin modifications was assessed with ENCODE ChIP-seq from blood
(GM12878, K562) and endothelial (HUVEC) cell lines [26]. Associations between transcrip-
tion and DNAmethylation at CpGs along theMYO1G locus was retrieved from the pan-cancer
methylation database MethHC [25]. General and tobacco-related expression pattern of
CNTNAP2 and FRMD4A was assessed using Human Proteome Map [45] and Gene Expression
Atlas at the European Bioinformatics Institute [42], respectively. All data were last retrieved in
February 2016.
Functional network analysis
Functional interpretation of our top five differentially methylated CpG sites (FDR<0.05) was
performed using the GeneMANIA (http://genemania.org/) [11]. The network of 100 most
strongly interacting genes with MYO1G, CNTNAP2 and FRMD4A was created based on phys-
ical interactions, co-expression, co-localization and shared protein domains The predicted
interaction network was then analysed with the PANTHER (protein annotation through evolu-
tionary relationship) classification system, version 10.0, released 2015-05-15, using the statisti-
cal overrepresentation test for gene ontology (GO) terms, protein classes and PANTHER
pathways (http://pantherdb.org/index.jsp).
Supporting Information
S1 Fig. Chromatin and transcription alongMYO1G locus in human hematopoietic
(G12878, K562) and endothelial (HUVEC) cell lines (http://genome-euro.ucsc.edu/cgi-bin/
hgTracks?db=hg19&lastVirtModeType=default&lastVirtModeExtraState=
&virtModeType=default&virtMode=0&nonVirtPosition=&position=chr7%3A44998414-
45023390&hgsid=212237736_XjE21xm20bpQVMUt2cQ6XC8wIHnm). In GM12878 cells,
high (>60%) DNAmethylation at the 3’ gene region associates with high transcription along
theMYO1G locus, high promoter histone 3 lysine 27 (H3K27) acetylation and low (<20%)
promoter DNA methylation. To the contrary, in K562 and HUVEC cellsMYO1G locus is not
transcribed and has a high (>60%) level of 3’methylation (K562), no promoter H3K27 acetyla-
tion and high (>60%) promoter DNA methylation. Significantly methylated CpG sites in our
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study are among those in the red circle.
(TIF)
S2 Fig. MYO1G transcription in bladderurothelial carcinoma (blca) inversely correlates with
methylation of promoter/5’UTR CpGs (A) and directly correlates with methylation of CpGs at
the 3’gene region (B) (http://methhc.mbc.nctu.edu.tw/php/correlation_probe.php?nm=NM_
033054&tumor=blca&region=5UTR&levelmethod=mean&probe=cg21188037). Abbrevia-
tions: TSS200, 200 bp—long region upstream of the transcription start site (TSS); CGI, CpG
island.
(TIFF)
S3 Fig. Prenatal smoking-associated differentially methylatedMYO1G 3’gene region over-




ated CpG sites in our study are marked by red circles. Grey intensity of DNA binding factors is
proportional to the maximum strength signal observed. Abbreviations: POLR2A, RNA poly-
merase II; MAX, Myc-associated factor; EZH2, enhancer of zeste homolog 2; TAF1, TBP-asso-
ciated factor; USF2, upstream stimulatory factor 2; YY1, Yin and Yang 1 protein; RAD21,
double-strand-break repair protein rad21 homolog; CTCF, Insulator protein (CCCTC-binding
factor); USF1, upstream stimulatory factor 1.
(TIF)
S4 Fig. Smoking-associated hypomethylated cg25949550 is located at the 5’ region of
CNTNAP2 and overlaps with binding sites of transcription repressors SIN3A, CTBP2,
CTCF and REST (http://genome-euro.ucsc.edu/cgi-bin/hgTracks?hgS_doOtherUser=
submit&hgS_otherUserName=suncanica&hgS_otherUserSessionName=Fig_S4_
CNTNAP2). Significantly methylated CpG sites in our study are marked by the red circle.
Abbreviations: SIN3A, SIN3 transcription regulator family member A; CTBP2, C-terminal-
binding protein 2; CTCF, Insulator protein (CCCTC-binding factor); REST, RE1-silencing
transcription factor.
(TIFF)
S5 Fig. Prenatal smoking-hypermethylated cg11813497 is located at the FRMD4A pro-
moter region next to the binding site for Gata-2 and a conserved binding site for the Tst1/
Oct/Pou family of transcription factors (http://genome-euro.ucsc.edu/cgi-bin/hgTracks?
hgS_doOtherUser=submit&hgS_otherUserName=suncanica&hgS_
otherUserSessionName=Fig_S5_FRMD4A). Significantly methylated CpG sites in our study
are marked by the red circle. Abbreviations: GATA2, Gata-binding protein 2; TST1; POU
domain transcription factor 1, also known as Oct-6; FREAC7, forkhead box protein L1;
FOXD3, forkhead box D3; HNF3B, hepatocyte nuclear factor 3-beta, also known as FOXA2;
OCT1, octamer-binding protein 1, also known as POU2F1; MEF2, myocyte enhancer factor-2;
GRE, glucocorticoid receptor; RSRFC4, myocyte enhancer factor-2a, known as MEF2A.
(TIFF)
S1 Table. Comparison of prenatal smoking associated differentially methylated CpGs in
children and adolescents. The table compares effect sizes, and uncorrected P-values across
cohorts. Values that remained significant after applying Bonferroni (SEED, 0.05/26 = 1.92 x
10−3) or Benjamini-Hochberg (ALSPAC, CHOP and SYS) corrections are indicated in bold.
Abbreviations: Chr, chromosome; Δβ, difference in DNAmethylation level between offspring
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exposed and non-exposed to prenatal tobacco smoke; SEED, The Study to Explore Early Devel-
opment; USA, the United States of America; CHOP, The European Childhood Obesity Project;
BE, Belgium; DE, Germany; IT, Italy; ES, Spain; ALSPAC, The Avon Longitudinal study of
Parents and Children; UK, the United Kingdom; SYS, The Saguenay Youth Study; Can, Can-
ada.Model adjustments: SEED: Model adjusted for genetically estimated racial ancestry, autism
spectrum disorder (ASD), sex, maternal education, maternal age, cell type proportions
(Table 2, [8]). CHOP: Model adjusted for age + sex + maternal education + cell type propor-
tions + 30 PC + study centre + postnatal parent smoking (Table 1, our study). ALSPAC-7.5 y.:
Model adjusted for paternal smoking (Table S8, [7]). SYS: Model adjusted for age, sex, batch
and blood cell fractions (Table 2 Model A, [6]). ALSPAC-17.7 y.: Model adjusted for paternal
smoking (Table S9, [7]).
(XLSX)
S2 Table. GeneMANIA gene list.
(XLSX)
S3 Table. PANTHER Pathways.
(XLSX)
S4 Table. GO biological process complete.
(XLSX)
S5 Table. GO molecular function complete.
(XLSX)
S6 Table. GO cellular component complete.
(XLSX)
S7 Table. PANTHER Protein Class.
(XLSX)
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